Zoledronic acid for the treatment of thalassemia-induced osteonecrosis
- PMID: 16956807
Zoledronic acid for the treatment of thalassemia-induced osteonecrosis
Comment on
-
Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial.Haematologica. 2006 Sep;91(9):1193-202. Haematologica. 2006. PMID: 16956818 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical